Results of the Health Assessment Questionnaire for Japanese patients with systemic sclerosis - Measuring functional impairment in systemic sclerosis versus other connective tissue diseases

Clinical and Experimental Rheumatology

Volumn 25, Issue 3, 2007, Pages 367-372

  Morita, Y ^a   Muro, Y ^a   Sugiura, K ^a   Tomita, Y ^a   Tamakoshi, K ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Connective tissue disease; Functional impairment; Health Assessment Questionnaire; Systemic sclerosis

Indexed keywords

ADULT; AGED; ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE SEVERITY; EATING; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; FUNCTIONAL STATUS; GRIP STRENGTH; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; OUTPATIENT; PATIENT ASSESSMENT; PATIENT SELECTION; PHYSICAL DISABILITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; WALKING;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CONNECTIVE TISSUE DISEASES; DISABILITY EVALUATION; FEMALE; HAND STRENGTH; HEALTH SURVEYS; HUMANS; JAPAN; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SKIN DISEASES; WALKING;

EID: 34447619918     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. LeROY EC, BLACK C, FLEISCHMAJER R et al.: Scleroderma (systemic sclerosis): Classification, subsets, and pathogenesis. J Rheumatol 1988; 15: 202-5.
2. MEDSGER TA JR, BOMBARDIERI S, CZIRJAK L, SCORZA R, DELLA ROSSA A, BENCIVELLI W: Assessment of disease severity and prognosis. Clin Exp Rheumatol 2003; 21: S42-6.
3. TAKEHARA K, SATO S: The clarification of pathogenesis and the development of therapy in systemic sclerosis: The classification of severity and the guideline for treatment (2004). A research project for systemic sclerosis supported by Japanese Ministry of Health and Welfare; 2004.
4. KVIEN TK, KAASA S, SMEDSTAD LM: Performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. II. A comparison of the SF-36 with disease-specific measures. J Clin Epidemiol 1998; 51: 1077-86.
5. MEENAN RF: The AIMS approach to health staCus measurement: conceptual background and measurement properties. J Rheumatol 1982; 9: 785-8.
6. FRIES JF, SPITZ PW, YOUNG DY:TThe dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol 1982; 9: 789-93.
7. WARE JE JR, SHERBOURNE CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-83.
8. KUWANA M, SATO S, KIKUCHI K et al.: Evaluation of functional disability using the Health Assessment Questionnaire in Japanese patients with systemic sclerosis. J Rheumatol 2003; 30: 1253-8.
9. RODNAN GP, LIPINSKI E, LUKSICK J: Skin thickness and collagen content in progressive systemic sclerosis (scleroderma) and localized scleroderma. Arthritis Rheum 1979; 22: 130-40.
10. BRUCE B, FRIES JF: The Health Assessment Questionnaire (HAQ). Clin Exp Rheumatol 2005; 23 (Suppl. 39): S14-18.
11. BELLAMY N: WOMAC: A 20-year experimental review of a patient-centered self-reported health status questionnaire. J Rheumatol 2002; 29: 2473-6.
12. POOLE JL, STEEN VD: The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis. Arthritis Care Res 1991; 4: 27-31.
13. STEEN VD, MEDSGER TA: The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997; 40: 1984-91.
14. POOLE JL, WILLIAMS CA, BLOCH DA, HOLLAK B, SPITZ P: Concurrent validity of the health assessment questionnaire disability index in scleroderma. Arthritis Care Res 1995; 8: 189-93.
15. KUWANA M, KABURAKI J, ARNETT FC et al.: Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase antibody. Arthritis Rheum 1999; 42: 465-74.
16. KABURAKI J, KAWAI S, KUWANA M, TOJO T, TAKANO M, FUNATSU Y: Quality of life in patients with systemic sclerosis. Jpn J Clin Immun 1991; 14: 626-32 (in Japanese).
17. CLEMENTS PJ, WONG WK, HURWITZ EL et al.: Correlates of the disability index of the Health Assessment Questionnaire: A measure of functional impairment in systemic sclerosis. Arthritis Rheum 1999; 42: 2372-80.
18. JOHNSON SR, HAWKER GA, DAVIS AM: The Health Assessment Questionnaire Disability Index and Scleroderma Health Assessment Questionnaire in scleroderma trials: An evaluation of their measurement properties. Arthritis Rheum 2005; 53: 256-62.